» Articles » PMID: 31732232

Donor-Recipient Relationship and Risk of ESKD in Live Kidney Donors of Varied Racial Groups

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 2019 Nov 17
PMID 31732232
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale & Objective: Risk factors for kidney failure are the basis of live kidney donor candidate evaluation. We quantified risk for end-stage kidney disease (ESKD) by the biological relationship of the donor to the recipient, a risk factor that is not addressed by current clinical practice guidelines.

Study Design: Retrospective cohort study.

Setting & Participants: A cohort of 143,750 US kidney donors between 1987 and 2017.

Exposure: Biological relationship of donor and recipient.

Outcome: ESKD. Donors' records were linked to national dialysis and transplantation registries to ascertain development of the outcome.

Analytic Approach: Donors were observed over a median of 12 (interquartile range, 6-18; maximum, 30) years. Survival analysis methods that account for the competing risk for death were used.

Results: Risk for ESKD varied by orders of magnitude across donor-recipient relationship categories. For Asian donors, risks compared with unrelated donors were 259.4-fold greater for identical twins (95% CI, 19.5-3445.6), 4.7-fold greater for full siblings (95% CI, 0.5-41.0), 3.5-fold greater for offspring (95% CI, 0.6-39.5), 1.0 for parents, and 1.0 for half-sibling or other biological relatives. For black donors, risks were 22.5-fold greater for identical twin donors (95% CI, 4.7-107.0), 4.1-fold for full siblings (95% CI, 2.1-7.8), 2.7-fold for offspring (95% CI, 1.4-5.4), 3.1-fold for parents (95% CI, 1.4-6.8), and 1.3-fold for half-sibling or other biological relatives (95% CI, 0.5-3.3). For white donors, risks were 3.5-fold greater for identical twin donors (95% CI, 0.5-25.3), 2.0-fold for full siblings (95% CI, 1.4-2.8), 1.4-fold for offspring (95% CI, 0.9-2.3), 2.9-fold for parents (95% CI, 2.0-4.1), and 0.8-fold for half-sibling or other biological relatives (95% CI, 0.3-1.6).

Limitations: Insufficient sample size in some race and relationship groups. Absence of data for family history of kidney disease for donors biologically unrelated to their recipients.

Conclusions: Marked differences in risk for ESKD across types of donor-recipient relationship were observed for Asian, black, and white donors. These findings warrant further validation with more robust data to better inform clinical practice guidelines.

Citing Articles

Genetic Assessment of Living Kidney Transplant Donors: A Survey of Canadian Practices.

Zahran S, Bei K, Adil A, Okoh P, Kitzler T, Alam A Can J Kidney Health Dis. 2025; 12():20543581241293200.

PMID: 39802879 PMC: 11724417. DOI: 10.1177/20543581241293200.


Aortic stiffness after living kidney donation: a systematic review and meta-analysis.

Rodriguez R, McNeill K, Agharazii M, Bugeja A, Clark E, Burns K BMJ Open. 2024; 14(12):e082725.

PMID: 39638601 PMC: 11624726. DOI: 10.1136/bmjopen-2023-082725.


The impact of COVID-19 on kidney transplant care.

Zhang C, Kodali L, Mour G, Jadlowiec C, Mathur A Front Med (Lausanne). 2023; 9:1093126.

PMID: 36698806 PMC: 9868174. DOI: 10.3389/fmed.2022.1093126.


The Living Kidney Donor Safety Study: Protocol of a Prospective Cohort Study.

Garg A, Arnold J, Cuerden M, Dipchand C, Feldman L, Gill J Can J Kidney Health Dis. 2022; 9:20543581221129442.

PMID: 36325263 PMC: 9619271. DOI: 10.1177/20543581221129442.


The Scope of Telemedicine in Kidney Transplantation: Access and Outreach Services.

Al Ammary F, Concepcion B, Yadav A Adv Chronic Kidney Dis. 2022; 28(6):542-547.

PMID: 35367022 PMC: 8989024. DOI: 10.1053/j.ackd.2021.10.003.


References
1.
Chapman A, Devuyst O, Eckardt K, Gansevoort R, Harris T, Horie S . Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2015; 88(1):17-27. PMC: 4913350. DOI: 10.1038/ki.2015.59. View

2.
Ibrahim H, Foley R, Reule S, Spong R, Kukla A, Issa N . Renal Function Profile in White Kidney Donors: The First 4 Decades. J Am Soc Nephrol. 2016; 27(9):2885-93. PMC: 5004661. DOI: 10.1681/ASN.2015091018. View

3.
Thomas C, Mansilla M, Sompallae R, Mason S, Nishimura C, Kimble M . Screening of Living Kidney Donors for Genetic Diseases Using a Comprehensive Genetic Testing Strategy. Am J Transplant. 2016; 17(2):401-410. PMC: 5297870. DOI: 10.1111/ajt.13970. View

4.
Riella L, Sheridan A . Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors. Am J Kidney Dis. 2015; 66(3):396-401. DOI: 10.1053/j.ajkd.2015.04.046. View

5.
Ong A, Devuyst O, Knebelmann B, Walz G . Autosomal dominant polycystic kidney disease: the changing face of clinical management. Lancet. 2015; 385(9981):1993-2002. DOI: 10.1016/S0140-6736(15)60907-2. View